AXSM
Axsome Therapeutics, Inc.
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $865M |
| Gross profit | $807M |
| Operating income | −$151M |
| Net income | −$157M |
| EPS | −$3.06 |
| Free cash flow | −$83M |
Axsome Therapeutics, Inc.
| Metric | Last 12 months |
|---|---|
| Revenue | $865M |
| Gross profit | $807M |
| Operating income | −$151M |
| Net income | −$157M |
| EPS | −$3.06 |
| Free cash flow | −$83M |